{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T14:58:25Z","timestamp":1767970705865,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T00:00:00Z","timestamp":1550448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00520-019-04688-2","type":"journal-article","created":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T13:01:54Z","timestamp":1550494914000},"page":"4083-4090","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Opioid-induced bowel dysfunction: suggestions from a multidisciplinary expert Board"],"prefix":"10.1007","volume":"27","author":[{"given":"Marco","family":"Rossi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Casale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danilo","family":"Badiali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Aielli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Antonietta","family":"Aloe Spiriti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Arcioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Bordin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Morelli Sbarra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Corcione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Marinangeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,18]]},"reference":[{"key":"4688_CR1","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s12325-017-0480-4","volume":"34","author":"R Epstein","year":"2017","unstructured":"Epstein R, Teagarden JR, Cimen A, Sostek M, Salimi T (2017) When people with opioid-induced constipation speak: a patient survey. Adv Ther 34:725\u2013731. \n                    https:\/\/doi.org\/10.1007\/s12325-017-0480-4","journal-title":"Adv Ther"},{"key":"4688_CR2","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1111\/nmo.12417","volume":"26","author":"M Camilleri","year":"2014","unstructured":"Camilleri M, Drossman DA, Becker G, Webster LR, Davies AN, Mawe GM (2014) Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid-induced constipation. Neurogastroenterol Motil 26:1386\u20131395. \n                    https:\/\/doi.org\/10.1111\/nmo.12417","journal-title":"Neurogastroenterol Motil"},{"key":"4688_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1080\/13543784.2018.1420778","volume":"27","author":"S Mozaffari","year":"2018","unstructured":"Mozaffari S, Nikfar S, Abdollahi M (2018) Investigational opioid antagonists for treating opioid-induced bowel dysfunction. Expert Opin Investig Drugs 27:235\u2013242. \n                    https:\/\/doi.org\/10.1080\/13543784.2018.1420778","journal-title":"Expert Opin Investig Drugs"},{"key":"4688_CR4","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1111\/pme.12937","volume":"16","author":"CE Argoff","year":"2015","unstructured":"Argoff CE, Brennan MJ, Camilleri M, Davies A, Fudin J, Galluzzi KE, Gudin J, Lembo A, Stanos SP, Webster LR (2015) Consensus recommendations on initiating prescription therapies for opioid-induced constipation. Pain Med 16:2324\u20132337. \n                    https:\/\/doi.org\/10.1111\/pme.12937","journal-title":"Pain Med"},{"key":"4688_CR5","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ijscr.2017.11.060","volume":"42","author":"R Poitras","year":"2018","unstructured":"Poitras R, Warren D, Oyogoa S (2018) Opioid drugs and stercoral perforation of the colon: case report and review of literature. Int J Surg Case Rep 42:94\u201397. \n                    https:\/\/doi.org\/10.1016\/j.ijscr.2017.11.060","journal-title":"Int J Surg Case Rep"},{"key":"4688_CR6","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1089\/acm.2011.0334","volume":"18","author":"J Gillett","year":"2012","unstructured":"Gillett J, Ientile C, Hiscock J, Plank A, Martin JM (2012) Complementary and alternative medicine use in radiotherapy: what are patients using? J Altern Complement Med 18:1014\u20131020. \n                    https:\/\/doi.org\/10.1089\/acm.2011.0334","journal-title":"J Altern Complement Med"},{"key":"4688_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.sjpain.2015.12.005","volume":"11","author":"AM Drewes","year":"2016","unstructured":"Drewes AM, Munkholm P, Simr\u00e9n M, Breivik H, Kongsgaard UE, Hatlebakk JG, Agreus L, Friedrichsen M, Christrup LL (2016) Definition, diagnosis and treatment strategies for opioid-induced bowel dysfunction-recommendations of the Nordic Working Group. Scand J Pain 11:111\u2013122. \n                    https:\/\/doi.org\/10.1016\/j.sjpain.2015.12.005","journal-title":"Scand J Pain"},{"key":"4688_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/ejp.970","volume":"21","author":"T O\u2019Brien","year":"2017","unstructured":"O\u2019Brien T, Christrup LL, Drewes AM, Fallon MT, Kress HG, McQuay HJ, Mikus G, Morlion BJ, Perez-Cajaraville J, Pogatzki-Zahn E, Varrassi G, Wells JC (2017) European Pain Federation position paper on appropriate opioid use in chronic pain management. Eur J Pain 21:3\u201319. \n                    https:\/\/doi.org\/10.1002\/ejp.970","journal-title":"Eur J Pain"},{"key":"4688_CR9","unstructured":"National Clinical Effectiveness Committee (2015) Management of constipation in adult patients receiving palliative care. National Clinical Guideline no. 10. Dublin: Department of Health. \n                    https:\/\/health.gov.ie\/wp-content\/uploads\/2015\/11\/Mgmt-of-Constipation-Guideline.pdf\n                    \n                   Accessed 13 May 2018"},{"key":"4688_CR10","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/S0016-5085(00)80553-3","volume":"43","author":"CH Knowles","year":"2000","unstructured":"Knowles CH, Eccersley AJ, Scott SM, Walker SM, Reeves B, Lunniss PJ (2000) Linear discriminant analysis of symptoms in patients with chronic constipation: validation of a new scoring system (KESS). Dis Colon Rectum 43:1419\u20131426. \n                    https:\/\/doi.org\/10.1016\/S0016-5085(00)80553-3","journal-title":"Dis Colon Rectum"},{"key":"4688_CR11","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/j.1365-2982.2011.01709.x","volume":"23","author":"J Tack","year":"2011","unstructured":"Tack J, M\u00fcller-Lissner S, Stanghellini V, Boeckxstaens G, Kamm MA, Simren M, Galmiche JP, Fried M (2011) Diagnosis and treatment of chronic constipation - a European perspective. Neurogastroenterol Motil 23:697\u2013710. \n                    https:\/\/doi.org\/10.1111\/j.1365-2982.2011.01709.x","journal-title":"Neurogastroenterol Motil"},{"key":"4688_CR12","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1093\/pm\/pnw255","volume":"18","author":"S M\u00fcller-Lissner","year":"2017","unstructured":"M\u00fcller-Lissner S, Bassotti G, Coffin B, Drewes AM, Breivik H, Eisenberg E, Emmanuel A, Laroche F, Meissner W, Morlion B (2017) Opioid-induced constipation and bowel dysfunction: a clinical guideline. Pain Med 18:1837\u20131863. \n                    https:\/\/doi.org\/10.1093\/pm\/pnw255","journal-title":"Pain Med"},{"key":"4688_CR13","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1177\/0269216308096908","volume":"22","author":"PJ Larkin","year":"2008","unstructured":"Larkin PJ, Sykes NP, Centeno C, Ellershaw JE, Elsner F, Eugene B, Gootjes JR, Nabal M, Noguera A, Ripamonti C, Zucco F, Zuurmond WW, European Consensus Group on Constipation in Palliative Care (2008) The management of constipation in palliative care: clinical practice recommendations. Palliat Med 22:796\u2013807. \n                    https:\/\/doi.org\/10.1177\/0269216308096908","journal-title":"Palliat Med"},{"key":"4688_CR14","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1111\/j.1742-1241.2007.01415.x","volume":"61","author":"SJ Panchal","year":"2007","unstructured":"Panchal SJ, M\u00fcller-Schwefe P, Wurzelmann JI (2007) Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden. Int J Clin Pract 61:1181\u20131187. \n                    https:\/\/doi.org\/10.1111\/j.1742-1241.2007.01415.x","journal-title":"Int J Clin Pract"},{"key":"4688_CR15","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1001\/jama.2015.16994","volume":"315","author":"A Wald","year":"2016","unstructured":"Wald A (2016) Constipation: advances in diagnosis and treatment. JAMA 315:185\u2013191. \n                    https:\/\/doi.org\/10.1001\/jama.2015.16994","journal-title":"JAMA"},{"key":"4688_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/2040622315627801","volume":"7","author":"AD Nelson","year":"2016","unstructured":"Nelson AD, Camilleri M (2016) Opioid-induced constipation: advances and clinical guidance. Ther Adv Chronic Dis 7:121\u2013134. \n                    https:\/\/doi.org\/10.1177\/2040622315627801","journal-title":"Ther Adv Chronic Dis"},{"key":"4688_CR17","first-page":"41","volume-title":"Goodman and Gilman\u2019s the pharmacological basis of therapeutics","author":"DK Blumenthal","year":"2011","unstructured":"Blumenthal DK, Garrison JC (2011) Pharmadynamics: molecular mechanisms of drug action. In: Brunton LL, Chabner BA, Knollmann BC (eds) Goodman and Gilman\u2019s the pharmacological basis of therapeutics. McGraw-Hill, New York, pp 41\u201372"},{"key":"4688_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12876-016-0556-7","volume":"17","author":"M Bellini","year":"2017","unstructured":"Bellini M, Usai-Satta P, Bove A, Bocchini R, Galeazzi F, Battaglia E, Alduini P, Buscarini E, Bassotti G, ChroCoDiTE Study Group, AIGO (2017) Chronic constipation diagnosis and treatment evaluation: the \u201cCHRO.CO.DI.T.E.\u201d study. BMC Gastroenterol 17:11. \n                    https:\/\/doi.org\/10.1186\/s12876-016-0556-7","journal-title":"BMC Gastroenterol"},{"key":"4688_CR19","first-page":"217","volume":"59","author":"V Stanghellini","year":"2013","unstructured":"Stanghellini V, Bellacosa L, Cogliandro R (2013) Fiber and macrogol in the therapy of chronic constipation. Minerva Gastroenterol Dietol 59:217\u2013230","journal-title":"Minerva Gastroenterol Dietol"},{"key":"4688_CR20","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1177\/104990910502200511","volume":"22","author":"S Wirz","year":"2005","unstructured":"Wirz S, Klaschik E (2005) Management of constipation in palliative care patients undergoing opioid therapy: is polyethylene glycol an option? Am J Hosp Palliat Care 22:375\u2013381. \n                    https:\/\/doi.org\/10.1177\/104990910502200511","journal-title":"Am J Hosp Palliat Care"},{"key":"4688_CR21","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1365-2982.2006.00760.x","volume":"18","author":"TL Abell","year":"2006","unstructured":"Abell TL, Bernstein RK, Cutts T, Farrugia G, Forster J, Hasler WL, McCallum RW, Olden KW, Parkman HP, Parrish CR, Pasricha PJ, Prather CM, Soffer EE, Twillman R, Vinik AI (2006) Treatment of gastroparesis: a multidisciplinary clinical review. Neurogastroenterol Motil 18:263\u2013283. \n                    https:\/\/doi.org\/10.1111\/j.1365-2982.2006.00760.x","journal-title":"Neurogastroenterol Motil"},{"key":"4688_CR22","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1007\/s10620-010-1229-y","volume":"55","author":"CE Sloots","year":"2010","unstructured":"Sloots CE, Rykx A, Cools M, Kerstens R, De Pauw M (2010) Efficacy and safety of prucalopride in patients with chronic noncancer pain suffering from opioid-induced constipation. Dig Dis Sci 55:2912\u20132921. \n                    https:\/\/doi.org\/10.1007\/s10620-010-1229-y","journal-title":"Dig Dis Sci"},{"key":"4688_CR23","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1080\/14740338.2017.1361402","volume":"16","author":"B Serrano-Falc\u00f3n","year":"2017","unstructured":"Serrano-Falc\u00f3n B, Rey E (2017) The safety of available treatments for chronic constipation. Expert Opin Drug Saf 16:1243\u20131253. \n                    https:\/\/doi.org\/10.1080\/14740338.2017.1361402","journal-title":"Expert Opin Drug Saf"},{"key":"4688_CR24","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.2165\/11634970-000000000-00000","volume":"72","author":"C Brock","year":"2012","unstructured":"Brock C, Olesen SS, Olesen AE, Fr\u00f8kjaer JB, Andresen T, Drewes AM (2012) Opioid-induced bowel dysfunction: pathophysiology and management. Drugs 72:1847\u20131865. \n                    https:\/\/doi.org\/10.2165\/11634970-000000000-00000","journal-title":"Drugs"},{"key":"4688_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/pme.12233","volume":"15","author":"E Michna","year":"2014","unstructured":"Michna E, Cheng WY, Korves C, Birnbaum H, Andrews R, Zhou Z, Joshi AV, Schaaf D, Mardekian J, Sheng M (2014) Systematic literature review and meta-analysis of the efficacy and safety of prescription opioids, including abuse-deterrent formulations, in non-cancer pain management. Pain Med 15:79\u201392. \n                    https:\/\/doi.org\/10.1111\/pme.12233","journal-title":"Pain Med"},{"key":"4688_CR26","doi-asserted-by":"publisher","first-page":"188","DOI":"10.4103\/0976-500X.162015","volume":"6","author":"T Anantharamu","year":"2015","unstructured":"Anantharamu T, Sharma S, Gupta AK, Dahiya N, Singh Brashier DB, Sharma AK (2015) Naloxegol: first oral peripherally acting mu opioid receptor antagonists for opioid-induced constipation. J Pharmacol Pharmacother 6:188\u2013192. \n                    https:\/\/doi.org\/10.4103\/0976-500X.162015","journal-title":"J Pharmacol Pharmacother"},{"key":"4688_CR27","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jpainsymman.2006.01.001","volume":"31","author":"S Mercadante","year":"2006","unstructured":"Mercadante S, Porzio G, Ferrera P, Fulfaro F, Aielli F, Ficorella C, Verna L, Tirelli W, Villari P, Arcuri E (2006) Low morphine doses in opioid-naive cancer patients with pain. J Pain Symptom Manag 31:242\u2013247. \n                    https:\/\/doi.org\/10.1016\/j.jpainsymman.2006.01.001","journal-title":"J Pain Symptom Manag"},{"key":"4688_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j3313","volume":"358","author":"JW Boland","year":"2017","unstructured":"Boland JW, Boland EG (2017) Pharmacological therapies for opioid-induced constipation in adults with cancer. BMJ 358:j3313. \n                    https:\/\/doi.org\/10.1136\/bmj.j3313","journal-title":"BMJ"},{"key":"4688_CR29","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1056\/NEJMoa1310246","volume":"370","author":"WD Chey","year":"2014","unstructured":"Chey WD, Webster L, Sostek M, Lappalainen J, Barker PN, Tack J (2014) Naloxegol for opioid-induced constipation in patients with noncancer pain. N Engl J Med 370:2387\u20132396. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1310246","journal-title":"N Engl J Med"},{"key":"4688_CR30","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.cgh.2011.03.026","volume":"9","author":"MA Kamm","year":"2011","unstructured":"Kamm MA, Mueller-Lissner S, Wald A, Richter E, Swallow R, Gessner U (2011) Oral bisacodyl is effective and well-tolerated in patients with chronic constipation. Clin Gastroenterol Hepatol 9:577\u2013583. \n                    https:\/\/doi.org\/10.1016\/j.cgh.2011.03.026","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4688_CR31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1159\/000139865","volume":"47","author":"AP Passmore","year":"1993","unstructured":"Passmore AP, Davies KW, Flanagan PG, Stoker C, Scott MG (1993) A comparison of Agiolax and lactulose in elderly patients with chronic constipation. Pharmacology 47:249\u2013252. \n                    https:\/\/doi.org\/10.1159\/000139865","journal-title":"Pharmacology"},{"key":"4688_CR32","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1185\/03007995.2012.678938","volume":"28","author":"RF Wolff","year":"2012","unstructured":"Wolff RF, Aune D, Truyers C, Hernandez AV, Misso K, Riemsma R, Kleijnen J (2012) Systematic review of efficacy and safety of buprenorphine versus fentanyl or morphine in patients with chronic moderate to severe pain. Curr Med Res Opin 28:833\u2013845. \n                    https:\/\/doi.org\/10.1185\/03007995.2012.678938","journal-title":"Curr Med Res Opin"},{"key":"4688_CR33","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.pain.2013.04.024","volume":"154","author":"L Webster","year":"2013","unstructured":"Webster L, Dhar S, Eldon M, Masuoka L, Lappalainen J, Sostek M (2013) A phase 2, double-blind, randomized, placebo-controlled, dose-escalation study to evaluate the efficacy, safety, and tolerability of naloxegol in patients with opioid-induced constipation. Pain 154:1542\u20131550. \n                    https:\/\/doi.org\/10.1016\/j.pain.2013.04.024","journal-title":"Pain"},{"key":"4688_CR34","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/apt.12899","volume":"40","author":"L Webster","year":"2014","unstructured":"Webster L, Chey WD, Tack J, Lappalainen J, Diva U, Sostek M (2014) Randomised clinical trial: the long-term safety and tolerability of naloxegol in patients with pain and opioid-induced constipation. Aliment Pharmacol Ther 40:771\u2013779. \n                    https:\/\/doi.org\/10.1111\/apt.12899","journal-title":"Aliment Pharmacol Ther"},{"key":"4688_CR35","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2147\/PPA.S78042","volume":"11","author":"JV Pergolizzi Jr","year":"2017","unstructured":"Pergolizzi JV Jr, Raffa RB, Pappagallo M, Fleischer C, Pergolizzi J 3rd, Zampogna G, Duval E, Hishmeh J, LeQuang JA, Taylor R Jr (2017) Peripherally acting \u03bc-opioid receptor antagonists as treatment options for constipation in noncancer pain patients on chronic opioid therapy. Patient Prefer Adherence 11:107\u2013119. \n                    https:\/\/doi.org\/10.2147\/PPA.S78042","journal-title":"Patient Prefer Adherence"},{"key":"4688_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/MED.0000000000000220","volume":"23","author":"HC Weber","year":"2016","unstructured":"Weber HC (2016) Opioid-induced constipation in chronic noncancer pain. Curr Opin Endocrinol Diabetes Obes 23:11\u201317. \n                    https:\/\/doi.org\/10.1097\/MED.0000000000000220","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"4688_CR37","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3945\/an.116.014407","volume":"8","author":"E Dimidi","year":"2017","unstructured":"Dimidi E, Christodoulides S, Scott SM, Whelan K (2017) Mechanisms of action of probiotics and the gastrointestinal microbiota on gut motility and constipation. Adv Nutr 8:484\u2013494. \n                    https:\/\/doi.org\/10.3945\/an.116.014407","journal-title":"Adv Nutr"},{"key":"4688_CR38","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1053\/j.gastro.2013.09.046","volume":"146","author":"EP Halmos","year":"2014","unstructured":"Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG (2014) A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology 146:67\u201375.e5. \n                    https:\/\/doi.org\/10.1053\/j.gastro.2013.09.046","journal-title":"Gastroenterology"},{"key":"4688_CR39","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s40262-016-0479-z","volume":"56","author":"K Bui","year":"2017","unstructured":"Bui K, Zhou D, Xu H, Floettmann E, Al-Huniti N (2017) Clinical pharmacokinetics and pharmacodynamics of naloxegol, a peripherally acting \u03bc-opioid receptor antagonist. Clin Pharmacokinet 56:573\u2013582. \n                    https:\/\/doi.org\/10.1007\/s40262-016-0479-z","journal-title":"Clin Pharmacokinet"},{"key":"4688_CR40","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s40265-015-0357-2","volume":"75","author":"KP Garnock-Jones","year":"2015","unstructured":"Garnock-Jones KP (2015) Naloxegol: a review of its use in patients with opioid-induced constipation. Drugs 75:419\u2013425. \n                    https:\/\/doi.org\/10.1007\/s40265-015-0357-2","journal-title":"Drugs"},{"key":"4688_CR41","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1002\/jcph.349","volume":"54","author":"K Bui","year":"2014","unstructured":"Bui K, She F, Sostek M (2014) The effects of renal impairment on the pharmacokinetics, safety, and tolerability of naloxegol. J Clin Pharmacol 54:1375\u20131382. \n                    https:\/\/doi.org\/10.1002\/jcph.349","journal-title":"J Clin Pharmacol"},{"key":"4688_CR42","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1007\/s12325-016-0365-y","volume":"33","author":"R Lawson","year":"2016","unstructured":"Lawson R, King F, Marsh K, Altincatal A, Cimen A (2016) Impact of treatment with naloxegol for opioid-induced constipation on patients\u2019 health state utility. Adv Ther 33:1331\u20131346. \n                    https:\/\/doi.org\/10.1007\/s12325-016-0365-y","journal-title":"Adv Ther"},{"key":"4688_CR43","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.ejpain.2004.12.003","volume":"9","author":"HC M\u00fcller-Busch","year":"2005","unstructured":"M\u00fcller-Busch HC, Lindena G, Tietze K, Woskanjan S (2005) Opioid switch in palliative care, opioid choice by clinical need and opioid availability. Eur J Pain 9:571\u2013579. \n                    https:\/\/doi.org\/10.1016\/j.ejpain.2004.12.003","journal-title":"Eur J Pain"},{"key":"4688_CR44","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2147\/JPR.S61326","volume":"8","author":"HC Bruner","year":"2015","unstructured":"Bruner HC, Atayee RS, Edmonds KP, Buckholz GT (2015) Clinical utility of naloxegol in the treatment of opioid-induced constipation. J Pain Res 8:289\u2013294. \n                    https:\/\/doi.org\/10.2147\/JPR.S61326","journal-title":"J Pain Res"},{"key":"4688_CR45","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1185\/03007995.2015.1047747","volume":"31","author":"MA Ueberall","year":"2015","unstructured":"Ueberall MA, Mueller-Schwefe GH (2015) Safety and efficacy of oxycodone\/naloxone vs. oxycodone vs. morphine for the treatment of chronic low back pain: results of a 12 week prospective, randomized, open-label blinded endpoint streamlined study with prolonged-release preparations. Curr Med Res Opin 31:1413\u20131429. \n                    https:\/\/doi.org\/10.1185\/03007995.2015.1047747","journal-title":"Curr Med Res Opin"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-019-04688-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-019-04688-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-019-04688-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T16:13:01Z","timestamp":1582042381000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-019-04688-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,18]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["4688"],"URL":"https:\/\/doi.org\/10.1007\/s00520-019-04688-2","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,18]]},"assertion":[{"value":"19 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.Dr. Rossi has full control of all primary data and agrees to allow the journal to view data if requested.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}